135
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections

ORCID Icon, , , , , , , , ORCID Icon, , & show all
Pages 133-143 | Published online: 18 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alena Laschtowitz, Christoph Roderburg, Frank Tacke & Raphael Mohr. (2023) Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art. Journal of Hepatocellular Carcinoma 10, pages 181-191.
Read now
Arno Kornberg, Linda Kaschny, Jennifer Kornberg & Helmut Friess. (2022) Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. Journal of Hepatocellular Carcinoma 9, pages 649-660.
Read now

Articles from other publishers (5)

Namjeong Kim, Sanghwa Kim, Yeonhwa Song, Inhee Choi, Su-Yeon Lee, Kang mo Kim, Hyung Chul Rhu, Ju Young Lee & Haeng Ran Seo. (2022) Chromenopyrimidinone exhibit antitumor effects through inhibition of CAP1 (Adenylyl cyclase-associated protein 1) expression in hepatocellular carcinoma. Chemico-Biological Interactions 365, pages 110066.
Crossref
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti & Alessandro Uzzau. (2022) Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Frontiers in Oncology 12.
Crossref
Safak Gül-Klein, Paulina Schmitz, Wenzel Schöning, Robert Öllinger, Georg Lurje, Sven Jonas, Deniz Uluk, Uwe Pelzer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, Ramin Raul Ossami Saidy & Dennis Eurich. (2022) The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation. Cancers 14:12, pages 2890.
Crossref
Arndt Vogel, Martina Sterneck, Florian Vondran, Oliver Waidmann, Ingo Klein, Udo Lindig, Silvio Nadalin, Utz Settmacher, Frank Tacke, Hans Jürgen Schlitt & Henning Wege. (2021) Der Einsatz der immunonkologischen Therapie beim hepatozellulären Karzinom im Kontext der Lebertransplantation Eine interdisziplinäre Risiko-Nutzen-Abwägung. Zeitschrift für Gastroenterologie 60:02, pages 184-191.
Crossref
Fredrik Åberg, Jenny Abrahamsson, Andreas Schult, William Bennet, Magnus Rizell & Malin Sternby‐Eilard. (2021) The RETREAT score provides valid predictions regarding hepatocellular carcinoma recurrence after liver transplantation. Transplant International 34:12, pages 2869-2874.
Crossref